Here are what the editors at HealthDay consider to be the most important developments in Urology for April 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
New Clinic Satisfaction Tool Provides Real-Time Feedback
THURSDAY, April 26, 2018 (HealthDay News) — A new clinic satisfaction tool improves communication and provides real-time feedback, according to a study published online April 14 in Neurosurgery.
Abstract/ Full Text (subscription or payment may be required)
Certain Anticholinergic Drugs Appear to Raise Dementia Risk
FRIDAY, April 27, 2018 (HealthDay News) — Use of anticholinergic drugs may be tied to a future diagnosis of dementia, according to a study published online April 25 in The BMJ.
Spermatogenesis Still Occurs in Men With Testicular Cancer
FRIDAY, April 27, 2018 (HealthDay News) — Spermatogenesis occurs in most men with testicular cancer, often away from tumors, according to a study published online April 17 in BJU International.
Saturday Is National Prescription Drug Take Back Day
THURSDAY, April 26, 2017 (HealthDay News) — The U.S. Drug Enforcement Administration and local agencies are holding the 15th National Prescription Drug Take Back Day across the country this Saturday, April 28.
Medicare Requiring Hospitals to Post Prices Online
WEDNESDAY, April 25, 2018 (HealthDay News) — U.S. hospitals will have to post their standard prices online and make it easier for patients to access their electronic medical records, Medicare officials said Tuesday.
Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI
TUESDAY, April 24, 2018 (HealthDay News) — Five-day nitrofurantoin is associated with increased likelihood of clinical and microbiological resolution compared with single-dose fosfomycin among women with lower urinary tract infection (UTI), according to a study published online April 22 in the Journal of the American Medical Association.
Patients Prefer Doctors Who Engage in Face-to-Face Visits
MONDAY, April 23, 2018 (HealthDay News) — Patients prefer physicians who engage in face-to-face (F2F) clinic visits, rather than those using an examination room computer (ERC), according to a research letter published online April 19 in JAMA Oncology.
Cancer Screening More Likely After a Previous False Positive
MONDAY, April 23, 2018 (HealthDay News) — Patients who previously had a false-positive breast or prostate cancer screening test result are more likely to have future screenings, according to a study published online April 23 in Cancer.
Lasting Outcome Similar for ULS, SSLF for Pelvic Organ Prolapse
TUESDAY, April 17, 2018 (HealthDay News) — For women with pelvic organ prolapse, there is no significant difference in five-year outcomes with uterosacral ligament suspension (ULS) and sacrospinous ligament fixation (SSLF) surgeries, and no difference in the success of perioperative behavioral therapy and pelvic floor muscle training (BPMT) or usual care, according to a study published in the April 17 issue of the Journal of the American Medical Association.
UTI Calculator Predicts Risk of Infant Urinary Tract Infection
TUESDAY, April 17, 2018 (HealthDay News) — The newly developed UTICalc calculator can be used to guide testing and treatment in children with suspected urinary tract infection (UTI), according to a study published online April 16 in JAMA Pediatrics.
Males With BRCA Mutations Have Increased Risk of Certain Cancers
TUESDAY, April 17, 2018 (HealthDay News) — Males with BRCA mutations have increased incidence of malignant disease, specifically prostate, melanoma, pancreas, and breast cancers, according to a research letter published online April 12 in JAMA Oncology.
Recommendations Developed on Gender Equity in Medicine
MONDAY, April 16, 2018 (HealthDay News) — In a position paper published online April 17 in the Annals of Internal Medicine, recommendations are provided aimed at addressing gender equity in physician compensation and career advancement opportunities.
Nonoptimized Drug Therapy Costs More Than $500 Billion Annually
MONDAY, April 16, 2018 (HealthDay News) — The estimated annual cost of drug-related morbidity and mortality resulting from nonoptimized medication therapy is more than half a trillion dollars in the United States, according to a study published online March 26 in the Annals of Pharmacotherapy.
Recent Years Saw Increase in Burden of Prior Authorization
THURSDAY, April 12, 2018 (HealthDay News) — The burden of prior authorization (PA) has increased over the past five years, and 92 percent of physicians report associated delays in access to care, according to the results of a survey published by the American Medical Association (AMA).
ZIKV RNA Often ID’d in Semen of Men With Symptomatic Infection
WEDNESDAY, April 11, 2018 (HealthDay News) — Zika virus (ZIKV) RNA is frequently present in the semen of men with symptomatic ZIKV infection and can persist for over six months, according to a study published in the April 12 issue of the New England Journal of Medicine.
Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer
WEDNESDAY, April 11, 2018 (HealthDay News) — Gemcitabine and cisplatin (GC) plus ipilimumab is associated with a 69 percent objective response rate and 61 percent one-year overall survival for patients with metastatic urothelial cancer, according to a study published in the May issue of European Urology.
Suggestions Offered to Reduce Physician Frustration With EHRs
TUESDAY, April 10, 2018 (HealthDay News) — Changes can be implemented to help reduce physician frustration with electronic health records (EHRs), according to an article published in Medical Economics.
Considerable Differences in Burden of Disease at State Level
TUESDAY, April 10, 2018 (HealthDay News) — There are considerable differences in the burden of disease at the state level, according to a study published in the April 10 issue of the Journal of the American Medical Association.
Group Exercise, Nutrition Aids Prostate Cancer Patients on ADT
TUESDAY, April 10, 2018 (HealthDay News) — Men on androgen-deprivation therapy (ADT) for prostate cancer may significantly benefit from a group exercise and nutrition program, according to a study published online March 5 in the Annals of Behavioral Medicine.
Whole Body CT Doesn’t Cut Mortality in Peds Blunt Trauma
TUESDAY, April 10, 2018 (HealthDay News) — Whole body computed tomography (WBCT) is not associated with reduced mortality compared with a selective CT approach among children with blunt trauma, according to a study published online April 9 in JAMA Pediatrics.
Interns’ Schedule Takes Toll on Sleep, Physical Activity, Mood
FRIDAY, April 6, 2018 (HealthDay News) — New interns’ intense and changing schedules take a toll on sleep, activity, and mood, according to a study published online March 14 in the Journal of General Internal Medicine.
ACA Marketplaces Expand Coverage for Chronically Ill
THURSDAY, April 5, 2018 (HealthDay News) — The Affordable Care Act’s Marketplaces covered a disproportionate share of non-elderly adults with high health care risks in the 2014 to 2015 time period, according to a study published in the April issue of Health Affairs.
Online Doc Reviews Don’t Reflect Patient Satisfaction Surveys
THURSDAY, April 5, 2018 (HealthDay News) — Online physician reviews do not reflect patient satisfaction surveys (PSSs), according to a study published in the April issue of the Mayo Clinic Proceedings.
Variations Identified in Free-Text Directions in E-Prescriptions
WEDNESDAY, April 4, 2018 (HealthDay News) — There is considerable variation in the quality of free-text patient directions (Sig) in electronic prescriptions (e-prescriptions), according to a study published online April 2 in the Journal of Managed Care & Specialty Pharmacy.
Metabolic Abnormalities Seen in Testicular Cancer Survivors
WEDNESDAY, April 4, 2018 (HealthDay News) — Testicular cancer survivors (TCS) have metabolic abnormalities characterized by hypertension and increased low-density lipoprotein (LDL) and total cholesterol, according to a study published in the March 1 issue of the Journal of the National Comprehensive Cancer Network.
Copyright © 2018 ScoutNews, LLC. All rights reserved.
